Cargando…

Anhang

Detalles Bibliográficos
Autores principales:	Heinzerling, Lucie, Hartmann, Anke, Hund, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121620/ http://dx.doi.org/10.1007/978-3-662-58012-7_8

Ejemplares similares

Anhänge
por: Murphy, Kenneth, et al.
Publicado: (2018)

Kutane Lymphome
por: Heinzerling, Lucie, et al.
Publicado: (2019)

Melanom
por: Heinzerling, Lucie, et al.
Publicado: (2019)

Kutane Lymphome
por: Heinzerling, Lucie, et al.
Publicado: (2013)

Pauli Manuscript Collection: Anhang
por: Budini, Paolo
Publicado: (2002)

Über Verschwörungstheorien und ihre Anhänger
por: Körner, Jürgen
Publicado: (2020)

MedAustron: Zuschlag für Magnetstahl - Anhänge
Publicado: (2010)

Neue Rechtsprechung des Bundesgerichts zum Arzthaftpflichtrecht: mit einem Anhang unveröffentlichter Urteile
por: Jäger, Peter
Publicado: (1999)

Pauli Manuscript Collection: Bemerkung über Objekt-transformation (O. T.) und Argumenttransformation (A. T.) (Anhang)
por: Pauli, Wolfgang
Publicado: (2002)

Vor und nach Paracelsus. Untersuchungen über Hohenheims Traditionsverbundenheit und Nachrichten über seine Anhânger
por: Pagel, Walter
Publicado: (1966)

Ueber Malaria—und andere Blutparasiten, nebst Anhang eine wirksame Methode der Chromatin — und Blutfärbung
por: Davidson, Andrew
Publicado: (1899)

Die Verordnung (EU) 2017/746 (IVDR) in der Praxis: Umsetzung von Anhang I in der Pathologie
por: Kahles, Andy, et al.
Publicado: (2023)

Fünf Divertimenti für 2 Klarinetten und Fagott; K. V. Anhang Nr. 229 [5 divertimentos]
por: Mozart, Wolfgang Amadeus, 1756-1791

Molekeln II (Elektronenhülle): nebst einem Anhang zu den Teilbänden I/1, I/2, I/3
por: Eucken, Arnold, et al.
Publicado: (1951)

Therapy Preferences in Melanoma Treatment - Willingness to Pay and Preference of Quality versus Length of Life of Patients, Physicians and Healthy Controls
por: Krammer, Ramona, et al.
Publicado: (2014)

Georg Christian Gottlieb Wedekind 1761–1831: Werdegang und Schicksal eines Arztes im Zeitalter der Aufklärung und der Französischen Revolution, mit einem Anhang: Wedekinds Diätetikvorlesung von 1789/90
por: Maehle, Andreas-Holger
Publicado: (1990)

Therapy preferences in melanoma treatment—Willingness to pay and preference of quality versus length of life of patients, physicians, healthy individuals and physicians with oncological disease
por: Weiss, Julia, et al.
Publicado: (2020)

Current Melanoma Treatments: Where Do We Stand?
por: Moreira, Alvaro, et al.
Publicado: (2021)

Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma
por: Krückel, Annika, et al.
Publicado: (2019)

Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?
por: Heinzerling, L, et al.
Publicado: (2014)

Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
por: Tomsitz, Dirk, et al.
Publicado: (2023)

Evaluating HIV Prevention Programs: Herpes Simplex Virus Type 2 Antibodies as Biomarker for Sexual Risk Behavior in Young Adults in Resource-Poor Countries
por: Behling, Juliane, et al.
Publicado: (2015)

Dual mTOR/DNA-PK Inhibitor CC-115 Induces Cell Death in Melanoma Cells and Has Radiosensitizing Potential
por: Bürkel, Felix, et al.
Publicado: (2020)

Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients
por: Kirchberger, Michael Constantin, et al.
Publicado: (2018)

The neurotrophin Neuritin1 (cpg15) is involved in melanoma migration, attachment independent growth, and vascular mimicry
por: Bosserhoff, Anja Katrin, et al.
Publicado: (2016)

Palbociclib Induces Senescence in Melanoma and Breast Cancer Cells and Leads to Additive Growth Arrest in Combination With Irradiation
por: Jost, Tina, et al.
Publicado: (2021)

Concealed complete response in melanoma patients under therapy with immune checkpoint inhibitors: two case reports
por: Schliep, Stefan, et al.
Publicado: (2018)

BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation
por: Hoyer, Stefanie, et al.
Publicado: (2021)

BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy
por: Dörrie, Jan, et al.
Publicado: (2018)

PARP inhibitors combined with ionizing radiation induce different effects in melanoma cells and healthy fibroblasts
por: Weigert, Verena, et al.
Publicado: (2020)

Kinase inhibitors increase individual radiation sensitivity in normal cells of cancer patients
por: Jost, Tina, et al.
Publicado: (2022)

Immune infiltrates impact on the prediction of prognosis and response to immunotherapy of melanoma patients
por: Vasaturo, Angela, et al.
Publicado: (2015)

Force-field-based minimizations of protein-ligand complexes in the blink of an eye
por: Heinzerling, Lennart, et al.
Publicado: (2013)

Inflammatory markers in autoimmunity induced by checkpoint inhibitors
por: Husain, Beate, et al.
Publicado: (2021)

Which melanoma patient carries a BRAF-mutation? A comparison of predictive models
por: Eigentler, Thomas, et al.
Publicado: (2016)

The Role of Immune Checkpoint Blockade in Uveal Melanoma
por: Wessely, Anja, et al.
Publicado: (2020)

Experiences of In-Patients with Skin Cancer in a German University Hospital Setting: A Cross-Sectional Survey
por: Steeb, Theresa, et al.
Publicado: (2021)

The Quality of Practice Guidelines for Melanoma: A Methodologic Appraisal with the AGREE II and AGREE-REX Instruments
por: Steeb, Theresa, et al.
Publicado: (2020)

Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma
por: Tomsitz, Dirk, et al.
Publicado: (2022)

Checkpoint-inhibitor induced Polyserositis with Edema
por: Zierold, Sarah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tp85gdolcvqpteij61ui6kcv85